Mar 04, 2021

NMRA approves Russia's Sputnik V vaccine against COVID-19 Featured

The National Medicine Regulatory Body has given approval for the emergency use of Russian Sputnik V vaccine to be used against COVID-19.

State Minister of Pharmaceutical Production, Supply and Regulation Channa Jayasumana said the National Medicines Regulatory Authority gave it’s approval for the emergency use of Sputnik V.

The Russian vaccine is the second one to be approved by the National Medicines Regulatory Authority which previously gave approval for the Oxford-AstraZeneca vaccine manufactured by the Serum Institute in India.

Jayasumana said Sri Lanka has submitted orders for the doses of the vaccine from Russia’s Gamaleya Research Institute.

Russia is yet to respond to the Sri Lanka's requests

Sri Lanka has so far received one million doses of Oxford-AstraZeneca vaccine manufactured in the neighboring India which donated half of the doses while Sri Lanka purchased the balance from India’s Serum Institute.

Sri Lankan launched it’s COVID-19 vaccination program in January, by giving the vaccine firstly to the frontline health workers and thereafter to the public. So far, the vaccine has been given to more than 550,000 persons.

Sri Lanka also plans to purchase 10 million doses of Oxford-AstraZeneca vaccines for $ 52.5 million as a direct procurement from the Serum Institute. Sri Lanka will get another3.5 million of the same vaccine from the AstraZeneca Institute in Britain.